Why is Sunrest Lifescie falling/rising?

As of 12-Sep, Sunrest Lifescience Ltd is currently priced at 49.10, showing no change (0.00%). The stock has underperformed in recent periods, with a 1-week decline of 0.20%, a 1-month drop of 5.58%, and a year-to-date decrease of 4.66%. Additionally, it has significantly lagged over the past year, with a decline of 23.76%, while the benchmark Sensex has only decreased by 1.08%. Today's performance indicates that the stock has outperformed its sector by 0.71%, but it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 44.44% against the 5-day average, indicating reduced interest in the stock.
Broader Market Context: In contrast to Sunrest Lifescience's recent performance, the Sensex has shown positive returns, gaining 1.51% over the past week and 2.56% over the past month. This suggests that while the broader market is experiencing upward momentum, Sunrest Lifescience is struggling to keep pace. The lack of available positive or negative factors further complicates the understanding of the stock's recent movements, as no specific catalysts or concerns have been identified to explain its performance relative to the market. Overall, the combination of poor stock performance, declining investor interest, and a strong benchmark performance contributes to the stock's current stagnation.